Showing results (141-150 of 345) with videos related to

Sort By:
Pageof 35
Plos One|April 28, 2015
Erythropoietin in the general population: reference ranges and clinical, biochemical and genetic correlatesNiels Grote Beverborg, Niek Verweij, Ijsbrand T Klip, et al.
Journal of Cardiac Failure|June 23, 2015
Validity and Predictive Value of a Portable Two-Channel Sleep-Screening Tool in the Identification of Sleep Apnea in Patients With Heart FailureGrietje E de Vries, Haye H van der Wal, Huib A M Kerstjens, et al.
American Heart Journal|March 30, 2013
Iron deficiency in chronic heart failure: an international pooled analysisIjsbrand T Klip, Josep Comin-Colet, Adriaan A Voors, et al.
JACC. Heart Failure|March 27, 2026
Diuretic Resistance Risk and the Efficacy of Natriuresis-Guided Diuretic Therapy in Acute Heart Failure: Post Hoc Analysis From the PUSH-AHF TrialLara E E C Zonneveld, Ambarish Pandey, Iris E Beldhuis, et al.
European Journal of Heart Failure|February 21, 2020
Long-term survivors of early breast cancer treated with chemotherapy are characterized by a pro-inflammatory biomarker profile compared to matched controlsJasper Tromp, Liselotte M Boerman, Iziah E Sama, et al.
European Journal of Heart Failure|July 14, 2025
Immune dysregulation as a key driver of peripartum cardiomyopathy - an exploratory advanced imaging and biomarker studyJulian Hoevelmann, Charle Viljoen, Tessa Kotze, et al.
Cancers|June 12, 2026
Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological MalignanciesKalliopi Keramida, Marianne C Aznar, Jutta Bergler-Klein, et al.
The American Journal of Cardiology|July 4, 2013
Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failureDirk J Lok, Ijsbrand T Klip, Sjoukje I Lok, et al.
JACC. Advances|November 25, 2024
Elevations of Cardiac Troponin in Patients Receiving Immune Checkpoint Inhibitors: Data From a Prospective StudyPieter F van den Berg, Valentina Bracun, Michel Noordman, et al.
European Journal of Heart Failure|July 23, 2022
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trialMarco Metra, Ewa A Jankowska, Matteo Pagnesi, et al.
Pageof 35